These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
221 related articles for article (PubMed ID: 21310057)
1. Access to artesunate-amodiaquine, quinine and other anti-malarials: policy and markets in Burundi. Amuasi JH; Diap G; Blay-Nguah S; Boakye I; Karikari PE; Dismas B; Karenzo J; Nsabiyumva L; Louie KS; Kiechel JR Malar J; 2011 Feb; 10():34. PubMed ID: 21310057 [TBL] [Abstract][Full Text] [Related]
2. Access to artemisinin-combination therapy (ACT) and other anti-malarials: national policy and markets in Sierra Leone. Amuasi JH; Diap G; Nguah SB; Karikari P; Boakye I; Jambai A; Lahai WK; Louie KS; Kiechel JR PLoS One; 2012; 7(10):e47733. PubMed ID: 23133522 [TBL] [Abstract][Full Text] [Related]
3. Access to artemisinin-based combination therapy (ACT) and quinine in malaria holoendemic regions of western Kenya. Watsierah CA; Ouma C Malar J; 2014 Jul; 13():290. PubMed ID: 25066600 [TBL] [Abstract][Full Text] [Related]
4. The malaria testing and treatment landscape in mainland Tanzania, 2016. ; Michael D; Mkunde SP Malar J; 2017 Apr; 16(1):202. PubMed ID: 28521811 [TBL] [Abstract][Full Text] [Related]
5. A cross-sectional study of the availability and price of anti-malarial medicines and malaria rapid diagnostic tests in private sector retail drug outlets in rural Western Kenya, 2013. Kioko U; Riley C; Dellicour S; Were V; Ouma P; Gutman J; Kariuki S; Omar A; Desai M; Buff AM Malar J; 2016 Jul; 15(1):359. PubMed ID: 27406179 [TBL] [Abstract][Full Text] [Related]
6. Community coverage of an antimalarial combination of artesunate and amodiaquine in Makamba Province, Burundi, nine months after its introduction. Gerstl S; Cohuet S; Edoh K; Brasher C; Lesage A; Guthmann JP; Checchi F Malar J; 2007 Jul; 6():94. PubMed ID: 17640357 [TBL] [Abstract][Full Text] [Related]
7. Trends in access to anti-malarial treatment in the formal private sector in Uganda: an assessment of availability and affordability of first-line anti-malarials and diagnostics between 2007 and 2018. Kibira D; Ssebagereka A; van den Ham HA; Opigo J; Katamba H; Seru M; Reed T; Leufkens HG; Mantel-Teeuwisse AK Malar J; 2021 Mar; 20(1):142. PubMed ID: 33691704 [TBL] [Abstract][Full Text] [Related]
8. Provider knowledge of treatment policy and dosing regimen with artemether-lumefantrine and quinine in malaria-endemic areas of western Kenya. Watsierah CA; Onyango RO; Ombaka JH; Abong'o BO; Ouma C Malar J; 2012 Dec; 11():436. PubMed ID: 23273046 [TBL] [Abstract][Full Text] [Related]
10. Copayment mechanism in selected districts of Uganda: Availability, market share and price of quality assured artemisinin-based combination therapies in private drug outlets. Ocan M; Nambatya W; Otike C; Nakalembe L; Nsobya S PLoS One; 2024; 19(3):e0295198. PubMed ID: 38536824 [TBL] [Abstract][Full Text] [Related]
11. Economic evaluation of a policy change from single-agent treatment for suspected malaria to artesunate-amodiaquine for microscopically confirmed uncomplicated falciparum malaria in the Oussouye District of south-western Senegal. Agnamey P; Brasseur P; Cisse M; Gaye O; Dumoulin J; Rigal J; Taylor WR; Olliaro P Trop Med Int Health; 2005 Sep; 10(9):926-33. PubMed ID: 16135201 [TBL] [Abstract][Full Text] [Related]
12. Accessibility, availability and affordability of anti-malarials in a rural district in Kenya after implementation of a national subsidy scheme. Smith N; Obala A; Simiyu C; Menya D; Khwa-Otsyula B; O'Meara WP Malar J; 2011 Oct; 10():316. PubMed ID: 22029829 [TBL] [Abstract][Full Text] [Related]
13. Varying efficacy of artesunate+amodiaquine and artesunate+sulphadoxine-pyrimethamine for the treatment of uncomplicated falciparum malaria in the Democratic Republic of Congo: a report of two in-vivo studies. Bonnet M; Broek Iv; van Herp M; Urrutia PP; van Overmeir C; Kyomuhendo J; Ndosimao CN; Ashley E; Guthmann JP Malar J; 2009 Aug; 8():192. PubMed ID: 19664280 [TBL] [Abstract][Full Text] [Related]
14. The association between price, competition, and demand factors on private sector anti-malarial stocking and sales in western Kenya: considerations for the AMFm subsidy. O'Meara WP; Obala A; Thirumurthy H; Khwa-Otsyula B Malar J; 2013 Jun; 12():186. PubMed ID: 23738604 [TBL] [Abstract][Full Text] [Related]
15. Evidence on anti-malarial and diagnostic markets in Cambodia to guide malaria elimination strategies and policies. ; Phok S; Lek D Malar J; 2017 Apr; 16(1):171. PubMed ID: 28438204 [TBL] [Abstract][Full Text] [Related]
16. Case management of malaria fever in Cambodia: results from national anti-malarial outlet and household surveys. Littrell M; Gatakaa H; Phok S; Allen H; Yeung S; Chuor CM; Dysoley L; Socheat D; Spiers A; White C; Shewchuk T; Chavasse D; O'Connell KA Malar J; 2011 Oct; 10():328. PubMed ID: 22039922 [TBL] [Abstract][Full Text] [Related]